CLEARSIGNAL
CLEARSIGNAL
Turning Clinical Promise Into Institutional Yes
Turning Clinical Promise Into Institutional Yes
THE CLEARSIGNAL CLARITY & ADOPTION AUDIT™
THE CLEARSIGNAL CLARITY & ADOPTION AUDIT™
Stop Guessing
Stop Guessing
Stop Guessing
Stop Guessing
Why Adoption Stalls.
Why Adoption Stalls.
Why Adoption Stalls.
Why Adoption Stalls.
Start Knowing.
Start Knowing.
Start Knowing.
Start Knowing.
Before you invest in more messaging, another round of sales training, or a redesigned slide deck, you need to know one thing: where adoption is actually breaking down. The Audit finds the specific boulders stalling your product — and tells you exactly what to build first.
Before you invest in more messaging, another round of sales training, or a redesigned slide deck, you need to know one thing: where adoption is actually breaking down. The Audit finds the specific boulders stalling your product — and tells you exactly what to build first.
"The deal doesn't die at clinical review. It dies when your champion can't defend it in the room you'll never be in."
"The deal doesn't die at clinical review. It dies when your champion can't defend it in the room you'll never be in."
Find the Financial Boulders — identify exactly where the CFO's case is incomplete and what it will take to reframe your product from a cost to a protection
Find the Financial Boulders — identify exactly where the CFO's case is incomplete and what it will take to reframe your product from a cost to a protection
Surface the Quiet No — uncover the operational questions from nursing, supply chain, and pharmacy that are traveling upward before your champion ever presents
Surface the Quiet No — uncover the operational questions from nursing, supply chain, and pharmacy that are traveling upward before your champion ever presents
Name the Ghost Stakeholders — identify the billing coders, EHR teams, and compliance officers who never vote but can quietly kill a deal before it reaches the committee
Name the Ghost Stakeholders — identify the billing coders, EHR teams, and compliance officers who never vote but can quietly kill a deal before it reaches the committee
Get the Survival Prescription — a precise list of what to build, what to stop building, and what your champion needs in their hands before the next committee meeting
Get the Survival Prescription — a precise list of what to build, what to stop building, and what your champion needs in their hands before the next committee meeting
Walk away with clarity — not a theory, not a framework, but a specific map of where your adoption is breaking down and exactly what to fix first
Walk away with clarity — not a theory, not a framework, but a specific map of where your adoption is breaking down and exactly what to fix first
WHAT YOU RECEIVE
Prioritized Friction Map
Prioritized Friction Map
Hidden No-Go Report
Hidden No-Go Report
Field Reality Check
Field Reality Check
Survival Prescription
Survival Prescription
The Debrief
The Debrief
The Audit by the Numbers
The Audit by the Numbers
The Audit by the Numbers
$5,000
$5,000
$5,000
$5,000
Investment. ClearSignal only accepts Audit engagements where institutional friction is clearly identified during the discovery conversation. If the fit isn't right, I'll tell you before we move forward.
Investment. ClearSignal only accepts Audit engagements where institutional friction is clearly identified during the discovery conversation. If the fit isn't right, I'll tell you before we move forward.
Investment. ClearSignal only accepts Audit engagements where institutional friction is clearly identified during the discovery conversation. If the fit isn't right, I'll tell you before we move forward.
17
17
17
17
Average gap from clinical evidence
to standard practice
Average gap from
clinical evidence
to standard practice
Average gap from clinical evidence
to standard practice
5
5
5
5
Deliverables — including a live
debrief call
Deliverables — including
a live debrief call
Deliverables — including a live
debrief call
1
1
1
1
Diagnostic built specifically for wound care biologics and regenerative bioscience
Diagnostic built specifically for wound care biologics and regenerative bioscience
Diagnostic built specifically for wound care biologics and regenerative bioscience
THE THREE BOULDERS
Where Adoption Breaks Down — and What the Audit Finds
Most products don't stall because the science is weak. They stall at one of three predictable friction points. The Audit finds exactly which one — and what it will take to clear it.
Financial Risk: The CFO's Wall
The committee sees a $3,000 line item. They don't see the $45,000 readmission it prevents. Nobody has translated the clinical value into the institution's financial language — and until that translation exists, the safest move in the room is always to pause.
That's not a pricing problem. It's a framing problem. And it's fixable.
Operational Anxiety: The Floor's Resistance
Long before the committee votes, nursing leadership, supply chain, and pharmacy are already asking questions nobody has answered — where does it live, how long does prep take, who handles the charting. If those answers aren't in the room, the floor becomes a quiet no that travels upward fast.
The Audit surfaces those unanswered questions before they kill the next meeting.
Clinical Inertia: The Status Quo Is Free
The current standard of care is already budgeted, already trained for, already defended. Asking a committee to replace it means asking them to absorb new risk — clinical, financial, operational, reputational — all at once. Without a clear case for why change is safer than staying put, "not right now" is always the easiest answer in the room.
Clinical Inertia isn't stubbornness. It's institutional self-preservation. The Audit shows you how to address it.
THE THREE BOULDERS
Where Adoption Breaks Down — and What the Audit Finds
Most products don't stall because the science is weak. They stall at one of three predictable friction points. The Audit finds exactly which one — and what it will take to clear it.
Financial Risk: The CFO's Wall
The committee sees a $3,000 line item. They don't see the $45,000 readmission it prevents. Nobody has translated the clinical value into the institution's financial language — and until that translation exists, the safest move in the room is always to pause.
That's not a pricing problem. It's a framing problem. And it's fixable.
Operational Anxiety: The Floor's Resistance
Long before the committee votes, nursing leadership, supply chain, and pharmacy are already asking questions nobody has answered — where does it live, how long does prep take, who handles the charting. If those answers aren't in the room, the floor becomes a quiet no that travels upward fast.
The Audit surfaces those unanswered questions before they kill the next meeting.
Clinical Inertia: The Status Quo Is Free
The current standard of care is already budgeted, already trained for, already defended. Asking a committee to replace it means asking them to absorb new risk — clinical, financial, operational, reputational — all at once. Without a clear case for why change is safer than staying put, "not right now" is always the easiest answer in the room.
Clinical Inertia isn't stubbornness. It's institutional self-preservation. The Audit shows you how to address it.
THE THREE BOULDERS
Where Adoption Breaks Down — and What the Audit Finds
Most products don't stall because the science is weak. They stall at one of three predictable friction points. The Audit finds exactly which one — and what it will take to clear it.
Financial Risk: The CFO's Wall
The committee sees a $3,000 line item. They don't see the $45,000 readmission it prevents. Nobody has translated the clinical value into the institution's financial language — and until that translation exists, the safest move in the room is always to pause.
That's not a pricing problem. It's a framing problem. And it's fixable.
Operational Anxiety: The Floor's Resistance
Long before the committee votes, nursing leadership, supply chain, and pharmacy are already asking questions nobody has answered — where does it live, how long does prep take, who handles the charting. If those answers aren't in the room, the floor becomes a quiet no that travels upward fast.
The Audit surfaces those unanswered questions before they kill the next meeting.
Clinical Inertia: The Status Quo Is Free
The current standard of care is already budgeted, already trained for, already defended. Asking a committee to replace it means asking them to absorb new risk — clinical, financial, operational, reputational — all at once. Without a clear case for why change is safer than staying put, "not right now" is always the easiest answer in the room.
Clinical Inertia isn't stubbornness. It's institutional self-preservation. The Audit shows you how to address it.